This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others
by Sheraz Mian
Today's Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM (QCOM), as well as two micro-cap stocks CSP Inc. (CSPI) and AMCON Distributing Company (DIT).
Synopsys (SNPS) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Synopsys (SNPS) reachead $515.81 at the closing of the latest trading day, reflecting a +1.7% change compared to its last close.
Here is What to Know Beyond Why Synopsys, Inc. (SNPS) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Synopsys (SNPS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Synopsys Plunges 20% in 6 Months: Should You Buy the Dip?
by Subham Roy
SNPS is affected by the U.S.-China trade war and slow recovery across key business segments. Yet, its strategic collaborations and AI investments are upsides.
Synopsys (SNPS) Dips More Than Broader Market: What You Should Know
by Zacks Equity Research
Synopsys (SNPS) closed the most recent trading day at $492.89, moving -1.81% from the previous trading session.
Micron Becomes NVIDIA's Key Component Supplier: Time to Buy MU Stock?
by Anirudha Bhagat
While Micron's partnership with NVIDIA boosts its AI prospects, short-term challenges, including weak consumer spending and geopolitical risks, warrant caution.
Will the Buyout of Ansys' PowerArtist Business Aid KEYS Stock?
by Zacks Equity Research
Keysight is set to expand its design engineering software portfolio with the Ansys PowerArtist business buyout.
Brokers Suggest Investing in Synopsys (SNPS): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Synopsys (SNPS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Ansys & Synopsys to Offload Ansys PowerArtist to Keysight Technologies
by Zacks Equity Research
ANSYS and Synopsys sign a deal to sell Ansys' PowerArtist business to Keysight to gain regulatory approval.
Synopsys (SNPS) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Synopsys (SNPS) closed at $501.06, indicating a +1.49% shift from the previous trading day.
Credo Surges 284% in a Year: Is the Stock a Screaming Buy in 2025?
by Aniruddha Ganguly
CRDO's strong portfolio of Active Electrical Cables and Digital Signal Processor solutions make it a long-term pick.
Why Is Synopsys (SNPS) Down 6.3% Since Last Earnings Report?
by Zacks Equity Research
Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synopsys (SNPS) Stock Moves -0.28%: What You Should Know
by Zacks Equity Research
The latest trading day saw Synopsys (SNPS) settling at $485.36, representing a -0.28% change from its previous close.
Synopsys (SNPS) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Synopsys (SNPS) concluded the recent trading session at $495.82, signifying a -0.87% move from its prior day's close.
Synopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CDNS Rises 10% YTD: Should Investors Add the Stock to Their Portfolio?
by Vaishali Doshi
Demand for Cadence's robust product portfolio amid increasing design activity is promising, but external risks keep us on the sidelines.
Top Analyst Reports for Visa, Linde & Thermo Fisher Scientific
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Linde plc (LIN) and Thermo Fisher Scientific Inc. (TMO), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Autoscope Technologies Corporation (AATC).
Synopsys Plunges 13% in 6 Months: How to Play the Stock?
by Subham Roy
Despite near-term challenges in key markets, SNPS' AI-driven innovations and partnerships secure its long-term growth potential.
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Stock Market News for Dec 6, 2024
by Zacks Equity Research
U.S. stocks closed lower on Thursday as the record-breaking rally paused ahead of the release of Friday's jobs report.
Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Synopsys (SNPS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Synopsys Q4 Earnings Beat Estimates, Stock Dips 7% on Weak Guidance
by Zacks Equity Research
SNPS' Q4 results reflect an impressive rise in top and bottom lines, driven by strong growth across multiple business segments.
More All-Time Closing Highs on Big Day for Data
by Mark Vickery
We had a busy morning with economic data today, not only with the lower-than-expected private-sector payroll data from ADP (ADP) ahead of the open, but monthly Services PMI and Factory Orders, as well. We even saw a new Beige Book this afternoon.
Compared to Estimates, Synopsys (SNPS) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Synopsys (SNPS) give insight into how the company performed in the quarter ended October 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Synopsys (SNPS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Synopsys (SNPS) delivered earnings and revenue surprises of 3.34% and 0.23%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?